They found that the supplementation of short-chain fatty acids can significantly regulate neurotransmitter uptake and upregulate genes involved in astrocyte-neuron metabolic coupling (including Glul, Slc1a2, and Gstm1), thereby improving Alzheimer’s disease symptoms in mice. This evidence concerns the gene GSTM1 and early-onset autosomal dominant Alzheimer disease.